Literature DB >> 19485573

Delay eyeblink classical conditioning is impaired in Fragile X syndrome.

Michael J Tobia1, Diana S Woodruff-Pak.   

Abstract

The authors examined 400 ms delay eyeblink classical conditioning in 20 participants with Fragile X syndrome ages 17 to 77 years, and 20 age-matched, healthy control participants. The participants in the Fragile X group demonstrated impaired learning and abnormal conditioned response timing. Adults with Fragile X (n=16) were also tested at two successive 12-month follow-up sessions to examine reacquisition and long-term retention. Participants in groups who were older and younger than 45 years demonstrated significant learning during each reacquisition session. Younger participants demonstrated greater retention of the conditioned stimulus/unconditioned stimulus association at each follow-up session than older participants. Fragile X impairs the acquisition and timing of conditioned eyeblink responses, but with repeated training adults with Fragile X syndrome show significant plasticity. Copyright (c) 2009 APA, all rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19485573      PMCID: PMC2814536          DOI: 10.1037/a0015662

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  40 in total

1.  Reversible inactivation of the cerebellar interpositus nucleus completely prevents acquisition of the classically conditioned eye-blink response.

Authors:  D J Krupa; R F Thompson
Journal:  Learn Mem       Date:  1997 Mar-Apr       Impact factor: 2.460

2.  MRI-assessed volume of cerebellum correlates with associative learning.

Authors:  D S Woodruff-Pak; R W Vogel; M Ewers; J Coffey; O B Boyko; S K Lemieux
Journal:  Neurobiol Learn Mem       Date:  2001-11       Impact factor: 2.877

Review 3.  In search of memory traces.

Authors:  Richard F Thompson
Journal:  Annu Rev Psychol       Date:  2005       Impact factor: 24.137

4.  Functional mapping of human learning: a positron emission tomography activation study of eyeblink conditioning.

Authors:  T A Blaxton; T A Zeffiro; J D Gabrieli; S Y Bookheimer; M C Carrillo; W H Theodore; J F Disterhoft
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

5.  Conditioned-reflex facilitation in young and older adults.

Authors:  M A Flaten; D A Powell
Journal:  Exp Aging Res       Date:  1998 Oct-Dec       Impact factor: 1.645

6.  Prevalence of fragile X syndrome.

Authors:  G Turner; T Webb; S Wake; H Robinson
Journal:  Am J Med Genet       Date:  1996-07-12

7.  Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance.

Authors:  S H Mostofsky; M M Mazzocco; G Aakalu; I S Warsofsky; M B Denckla; A L Reiss
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

8.  Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei.

Authors:  P M Rodier; J L Ingram; B Tisdale; S Nelson; J Romano
Journal:  J Comp Neurol       Date:  1996-06-24       Impact factor: 3.215

9.  Longitudinal investigation of eyeblink classical conditioning in elderly human subjects.

Authors:  L S Ferrante; D S Woodruff-Pak
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1995-01       Impact factor: 4.077

10.  Five-year retention of the classically conditioned eyeblink response in young adult, middle-aged, and older humans.

Authors:  P R Solomon; D Flynn; J Mirak; M Brett; N Coslov; M Groccia
Journal:  Psychol Aging       Date:  1998-06
View more
  10 in total

1.  Eyeblink conditioning in the developing rabbit.

Authors:  Kevin L Brown; Diana S Woodruff-Pak
Journal:  Dev Psychobiol       Date:  2011-09-27       Impact factor: 3.038

2.  Intense and specialized dendritic localization of the fragile X mental retardation protein in binaural brainstem neurons: a comparative study in the alligator, chicken, gerbil, and human.

Authors:  Yuan Wang; Hitomi Sakano; Karisa Beebe; Maile R Brown; Rian de Laat; Mark Bothwell; Randy J Kulesza; Edwin W Rubel
Journal:  J Comp Neurol       Date:  2014-06-15       Impact factor: 3.215

Review 3.  The cerebellum, sensitive periods, and autism.

Authors:  Samuel S-H Wang; Alexander D Kloth; Aleksandra Badura
Journal:  Neuron       Date:  2014-08-06       Impact factor: 17.173

Review 4.  Eyeblink conditioning: a non-invasive biomarker for neurodevelopmental disorders.

Authors:  Bethany C Reeb-Sutherland; Nathan A Fox
Journal:  J Autism Dev Disord       Date:  2015-02

5.  Cerebellar associative sensory learning defects in five mouse autism models.

Authors:  Alexander D Kloth; Aleksandra Badura; Amy Li; Adriana Cherskov; Sara G Connolly; Andrea Giovannucci; M Ali Bangash; Giorgio Grasselli; Olga Peñagarikano; Claire Piochon; Peter T Tsai; Daniel H Geschwind; Christian Hansel; Mustafa Sahin; Toru Takumi; Paul F Worley; Samuel S-H Wang
Journal:  Elife       Date:  2015-07-09       Impact factor: 8.140

Review 6.  Cerebellar and Striatal Implications in Autism Spectrum Disorders: From Clinical Observations to Animal Models.

Authors:  Mathieu Thabault; Valentine Turpin; Alexandre Maisterrena; Mohamed Jaber; Matthieu Egloff; Laurie Galvan
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

Review 7.  The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models.

Authors:  Lisa Mapelli; Teresa Soda; Egidio D'Angelo; Francesca Prestori
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

8.  Modeling possible effects of atypical cerebellar processing on eyeblink conditioning in autism.

Authors:  Milen L Radell; Eduardo Mercado
Journal:  Cogn Affect Behav Neurosci       Date:  2014-09       Impact factor: 3.526

Review 9.  New roles for the cerebellum in health and disease.

Authors:  Stacey L Reeber; Tom S Otis; Roy V Sillitoe
Journal:  Front Syst Neurosci       Date:  2013-11-14

10.  Autism and Classical Eyeblink Conditioning: Performance Changes of the Conditioned Response Related to Autism Spectrum Disorder Diagnosis.

Authors:  John P Welsh; Jeffrey T Oristaglio
Journal:  Front Psychiatry       Date:  2016-08-11       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.